VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $126 | -97.0% | 19 | -97.0% | 0.00% | -100.0% |
| Q1 2023 | $4,251 | +68.2% | 626 | +83.0% | 0.00% | 0.0% |
| Q4 2022 | $2,527 | -15.8% | 342 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,000 | – | 342 | +2530.8% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 13 | -95.2% | 0.00% | -100.0% |
| Q4 2021 | $4,000 | +100.0% | 270 | +97.1% | 0.00% | 0.0% |
| Q3 2021 | $2,000 | -33.3% | 137 | -10.5% | 0.00% | 0.0% |
| Q2 2021 | $3,000 | +50.0% | 153 | +11.7% | 0.00% | 0.0% |
| Q1 2021 | $2,000 | 0.0% | 137 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,000 | – | 137 | +356.7% | 0.00% | – |
| Q2 2020 | $0 | – | 30 | -11.8% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 34 | -53.4% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 73 | +21.7% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 60 | +36.4% | 0.00% | – |
| Q4 2018 | $1,000 | – | 44 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |